W E Berdel|S Okamoto - JoVE Visualize

Showing results (81-90 of 942) with videos related to

Pageof 95

Sort By:

Onkologie|December 1, 1983

[Results of drug therapy of inoperable non-small cell lung carcinoma with VP 16-213 (Etoposide) and cis-platin. A phase II study]T Klippstein, M Graubner, W E Berdel, et al.

Journal of Lipid Mediators|September 1, 1990

Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitroS Danhauser-Riedl, A Himmelmann, G Steinhauser, et al.

European Journal of Cancer & Clinical Oncology|March 1, 1984

cis-Platinum (DDP) and VP 16-213 (etoposide) combination chemotherapy for advanced non-small cell lung cancer. A phase II clinical trialP S Mitrou, M Graubner, W E Berdel, et al.

Cancer Letters|December 24, 1992

Lack of therapeutic effects of platelet activating factor antagonists in WEHI-3B leukemia, human xenotransplanted colorectal and lung cancer and Lewis-lung tumor in vivoM Koenigsmann, M Zafferani, S Danhauser-Riedl, et al.

Immunobiology|December 1, 1982

Purification of human monocytes by adherence to polymeric fluorocarbon. Characterization of the monocyte-enriched cell fractionW E Berdel, U Fink, E Thiel, et al.

Annals of Hematology|March 4, 2003

Matrix metalloproteinase/integrin interactions as target for anti-angiogenic treatment strategiesT A Kessler, A Pfeifer, S Silletti, et al.

Leukemia & Lymphoma|October 21, 2003

Thalidomide for the treatment of acute myeloid leukemiaM B Steins, R Bieker, T Padró, et al.

Onkologie|December 1, 1990

Tumor necrosis factor in advanced colorectal cancer: a phase II study. A trial of the phase I/II study group of the Association for Medical Oncology of the German Cancer SocietyM E Heim, R Siegmund, H J Illiger, et al.

British Poultry Science|March 1, 1994

Comparison of energy metabolism during the growing period in quail lines selected for body weightY Maeda, K Kawabe, S Okamoto, et al.

Leukemia|October 19, 2007

Pim2 complements Flt3 wild-type receptor in hematopoietic progenitor cell transformationS Agrawal, S Koschmieder, N Bäumer, et al.

Pageof 95

Showing results (81-90 of 942) with videos related to

Sort By:

Pageof 95

Onkologie|December 1, 1983

[Results of drug therapy of inoperable non-small cell lung carcinoma with VP 16-213 (Etoposide) and cis-platin. A phase II study]T Klippstein, M Graubner, W E Berdel, et al.

Journal of Lipid Mediators|September 1, 1990

Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitroS Danhauser-Riedl, A Himmelmann, G Steinhauser, et al.

European Journal of Cancer & Clinical Oncology|March 1, 1984

cis-Platinum (DDP) and VP 16-213 (etoposide) combination chemotherapy for advanced non-small cell lung cancer. A phase II clinical trialP S Mitrou, M Graubner, W E Berdel, et al.

Cancer Letters|December 24, 1992

Lack of therapeutic effects of platelet activating factor antagonists in WEHI-3B leukemia, human xenotransplanted colorectal and lung cancer and Lewis-lung tumor in vivoM Koenigsmann, M Zafferani, S Danhauser-Riedl, et al.

Immunobiology|December 1, 1982

Purification of human monocytes by adherence to polymeric fluorocarbon. Characterization of the monocyte-enriched cell fractionW E Berdel, U Fink, E Thiel, et al.

Annals of Hematology|March 4, 2003

Matrix metalloproteinase/integrin interactions as target for anti-angiogenic treatment strategiesT A Kessler, A Pfeifer, S Silletti, et al.

Leukemia & Lymphoma|October 21, 2003

Thalidomide for the treatment of acute myeloid leukemiaM B Steins, R Bieker, T Padró, et al.

Onkologie|December 1, 1990

Tumor necrosis factor in advanced colorectal cancer: a phase II study. A trial of the phase I/II study group of the Association for Medical Oncology of the German Cancer SocietyM E Heim, R Siegmund, H J Illiger, et al.

British Poultry Science|March 1, 1994

Comparison of energy metabolism during the growing period in quail lines selected for body weightY Maeda, K Kawabe, S Okamoto, et al.

Leukemia|October 19, 2007

Pim2 complements Flt3 wild-type receptor in hematopoietic progenitor cell transformationS Agrawal, S Koschmieder, N Bäumer, et al.

Pageof 95